Fabian Zohren - 01 Jul 2024 Form 4 Insider Report for Merus N.V. (MRUS)

Role
Chief Medical Officer
Signature
/s/ Peter B. Silverman, attorney-in-fact Fabian Zohren
Issuer symbol
MRUS
Transactions as of
01 Jul 2024
Transactions value $
$0
Form type
4
Filing time
03 Jul 2024, 16:20:02
Next filing
31 Jan 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRUS Share Options (Right to Buy) Award $0 +184K $0.00 184K 01 Jul 2024 Ordinary Shares 184K $54.45 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options vest over a four-year period commencing July 1, 2024. 25% vest after one year and in 36 equal monthly installments thereafter.